한글목차

조영제 시장은 2023-2028년간 9억 2,510만 달러 확대되고, 예측 기간 동안 3.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

본 보고서에서는 조영제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 고령 인구 증가, 만성 질환 및 감염성 질환 증가, 의료비 지출 증가, 새로운 조영제 승인 등이 시장을 주도하고 있습니다.

이 보고서는 새로운 조영제 출시가 향후 몇 년동안 조영제 시장 성장을 주도하는 주요 요인 중 하나라고 밝혔습니다. 또한, 조영제 인젝터에 대한 연구 개발 증가와 조영제 생산량 증가는 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 조영제 시장(2018-2022년)
• 모달리티별 부문 분석(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 모달리티별

• 시장 세분화
• 비교 : 모달리티별
• X선/CT : 시장 규모와 예측(2023-2028년)
• 초음파 : 시장 규모와 예측(2023-2028년)
• MRI : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 모달리티별

제7장 시장 세분화 : 용도별

• 시장 세분화
• 비교 : 용도별
• 신경 질환 : 시장 규모와 예측(2023-2028년)
• 심혈관 질환 : 시장 규모와 예측(2023-2028년)
• 암 : 시장 규모와 예측(2023-2028년)
• 위장 질환 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아태평양 : 시장 규모와 예측(2023-2028년)
• 남미 : 시장 규모와 예측(2023-2028년)
• 중동 및 아프리카 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제, 기회 및 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회 및 성장 억제요인

제11장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Bayer AG
• Beijing Beilu Pharmaceutical Co. Ltd.
• Bracco Spa
• Covis Pharma GmbH
• GE Healthcare Technologies Inc.
• Guerbet
• iMAX Diagnostic Imaging Ltd.
• Interpharma Praha as
• Jodas Expoim Pvt. Ltd.
• Lantheus Holdings Inc.
• Livealth Biopharma Pvt. Ltd.
• M.Biotech Ltd.
• Nano Therapeutics Pvt. Ltd.
• Spago Nanomedical AB
• Taejoon Pharm Co. Ltd.

제13장 부록

영문목차

The contrast media market is forecasted to grow by USD 925.1 mn during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. The report on the contrast media market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population and chronic and infectious diseases, rise in healthcare spending, and approval of new contrast media.

Technavio's contrast media market is segmented as below:

By Modality

• X-ray/CT
• MRI
• Ultrasound

By Application

• Neurological disorders
• Cardiovascular disorders
• Cancer
• Gastrointestinal disorders
• Others

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the launch of new contrast media as one of the prime reasons driving the contrast media market growth during the next few years. Also, increasing research and development focus on contrast media injectors and increasing production of contrast media will lead to sizable demand in the market.

The report on the contrast media market covers the following areas:

• Contrast media market sizing
• Contrast media market forecast
• Contrast media market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contrast media market vendors that include Bayer AG, Beijing Beilu Pharmaceutical Co. Ltd., Blue Jet Healthcare Ltd., Bracco Spa, Covis Pharma GmbH, GE Healthcare Technologies Inc., Guerbet, iMAX Diagnostic Imaging Ltd., Interpharma Praha as, J. B. Chemicals and Pharmaceuticals Ltd, Jodas Expoim Pvt. Ltd., Lantheus Holdings Inc., Livealth Biopharma Pvt. Ltd., M.Biotech Ltd., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Taejoon Pharm Co. Ltd., and Unijules Life Sciences Ltd.. Also, the contrast media market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Modality
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Contrast Media Market 2018 - 2022
  • Historic Market Size - Data Table on Global Contrast Media Market 2018 - 2022 ($ million)
• 4.2 Modality segment analysis 2018 - 2022
  • Historic Market Size - Modality Segment 2018 - 2022 ($ million)
• 4.3 Application segment analysis 2018 - 2022
  • Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Modality

• 6.1 Market segments
  • Chart on Modality - Market share 2023-2028 (%)
  • Data Table on Modality - Market share 2023-2028 (%)
• 6.2 Comparison by Modality
  • Chart on Comparison by Modality
  • Data Table on Comparison by Modality
• 6.3 X-ray/CT - Market size and forecast 2023-2028
  • Chart on X-ray/CT - Market size and forecast 2023-2028 ($ million)
  • Data Table on X-ray/CT - Market size and forecast 2023-2028 ($ million)
  • Chart on X-ray/CT - Year-over-year growth 2023-2028 (%)
  • Data Table on X-ray/CT - Year-over-year growth 2023-2028 (%)
• 6.4 Ultrasound - Market size and forecast 2023-2028
  • Chart on Ultrasound - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ultrasound - Market size and forecast 2023-2028 ($ million)
  • Chart on Ultrasound - Year-over-year growth 2023-2028 (%)
  • Data Table on Ultrasound - Year-over-year growth 2023-2028 (%)
• 6.5 MRI - Market size and forecast 2023-2028
  • Chart on MRI - Market size and forecast 2023-2028 ($ million)
  • Data Table on MRI - Market size and forecast 2023-2028 ($ million)
  • Chart on MRI - Year-over-year growth 2023-2028 (%)
  • Data Table on MRI - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Modality
  • Market opportunity by Modality ($ million)
  • Data Table on Market opportunity by Modality ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
  • Chart on Application - Market share 2023-2028 (%)
  • Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 7.3 Neurological disorders - Market size and forecast 2023-2028
  • Chart on Neurological disorders - Market size and forecast 2023-2028 ($ million)
  • Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ million)
  • Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
  • Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
• 7.4 Cardiovascular disorders - Market size and forecast 2023-2028
  • Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ million)
  • Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ million)
  • Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
  • Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
• 7.5 Cancer - Market size and forecast 2023-2028
  • Chart on Cancer - Market size and forecast 2023-2028 ($ million)
  • Data Table on Cancer - Market size and forecast 2023-2028 ($ million)
  • Chart on Cancer - Year-over-year growth 2023-2028 (%)
  • Data Table on Cancer - Year-over-year growth 2023-2028 (%)
• 7.6 Gastrointestinal disorders - Market size and forecast 2023-2028
  • Chart on Gastrointestinal disorders - Market size and forecast 2023-2028 ($ million)
  • Data Table on Gastrointestinal disorders - Market size and forecast 2023-2028 ($ million)
  • Chart on Gastrointestinal disorders - Year-over-year growth 2023-2028 (%)
  • Data Table on Gastrointestinal disorders - Year-over-year growth 2023-2028 (%)
• 7.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.8 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 APAC - Market size and forecast 2023-2028
  • Chart on APAC - Market size and forecast 2023-2028 ($ million)
  • Data Table on APAC - Market size and forecast 2023-2028 ($ million)
  • Chart on APAC - Year-over-year growth 2023-2028 (%)
  • Data Table on APAC - Year-over-year growth 2023-2028 (%)
• 9.6 South America - Market size and forecast 2023-2028
  • Chart on South America - Market size and forecast 2023-2028 ($ million)
  • Data Table on South America - Market size and forecast 2023-2028 ($ million)
  • Chart on South America - Year-over-year growth 2023-2028 (%)
  • Data Table on South America - Year-over-year growth 2023-2028 (%)
• 9.7 Middle East and Africa - Market size and forecast 2023-2028
  • Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
  • Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
  • Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
  • Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• 9.8 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.13 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
• 12.4 Beijing Beilu Pharmaceutical Co. Ltd.
  • Beijing Beilu Pharmaceutical Co. Ltd. - Overview
  • Beijing Beilu Pharmaceutical Co. Ltd. - Product / Service
  • Beijing Beilu Pharmaceutical Co. Ltd. - Key offerings
• 12.5 Bracco Spa
  • Bracco Spa - Overview
  • Bracco Spa - Product / Service
  • Bracco Spa - Key offerings
• 12.6 Covis Pharma GmbH
  • Covis Pharma GmbH - Overview
  • Covis Pharma GmbH - Product / Service
  • Covis Pharma GmbH - Key offerings
• 12.7 GE Healthcare Technologies Inc.
  • GE Healthcare Technologies Inc. - Overview
  • GE Healthcare Technologies Inc. - Business segments
  • GE Healthcare Technologies Inc. - Key news
  • GE Healthcare Technologies Inc. - Key offerings
  • GE Healthcare Technologies Inc. - Segment focus
• 12.8 Guerbet
  • Guerbet - Overview
  • Guerbet - Product / Service
  • Guerbet - Key offerings
• 12.9 iMAX Diagnostic Imaging Ltd.
  • iMAX Diagnostic Imaging Ltd. - Overview
  • iMAX Diagnostic Imaging Ltd. - Product / Service
  • iMAX Diagnostic Imaging Ltd. - Key offerings
• 12.10 Interpharma Praha as
  • Interpharma Praha as - Overview
  • Interpharma Praha as - Product / Service
  • Interpharma Praha as - Key offerings
• 12.11 Jodas Expoim Pvt. Ltd.
  • Jodas Expoim Pvt. Ltd. - Overview
  • Jodas Expoim Pvt. Ltd. - Product / Service
  • Jodas Expoim Pvt. Ltd. - Key offerings
• 12.12 Lantheus Holdings Inc.
  • Lantheus Holdings Inc. - Overview
  • Lantheus Holdings Inc. - Business segments
  • Lantheus Holdings Inc. - Key offerings
  • Lantheus Holdings Inc. - Segment focus
• 12.13 Livealth Biopharma Pvt. Ltd.
  • Livealth Biopharma Pvt. Ltd. - Overview
  • Livealth Biopharma Pvt. Ltd. - Product / Service
  • Livealth Biopharma Pvt. Ltd. - Key offerings
• 12.14 M.Biotech Ltd.
  • M.Biotech Ltd. - Overview
  • M.Biotech Ltd. - Product / Service
  • M.Biotech Ltd. - Key offerings
• 12.15 Nano Therapeutics Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd. - Overview
  • Nano Therapeutics Pvt. Ltd. - Product / Service
  • Nano Therapeutics Pvt. Ltd. - Key offerings
• 12.16 Spago Nanomedical AB
  • Spago Nanomedical AB - Overview
  • Spago Nanomedical AB - Product / Service
  • Spago Nanomedical AB - Key offerings
• 12.17 Taejoon Pharm Co. Ltd.
  • Taejoon Pharm Co. Ltd. - Overview
  • Taejoon Pharm Co. Ltd. - Product / Service
  • Taejoon Pharm Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.5 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations